PTC Therapeutics. has filed a patent for pharmaceutical compositions containing Compound 1 to treat diseases like a-synucleinpathy, liver diseases, and more. The composition includes specific percentages of oil, propylene glycol laurates, polysorbate 80, and Compound 1. GlobalData’s report on PTC Therapeutics gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on PTC Therapeutics, Human telomerase RT biomarker was a key innovation area identified from patents. PTC Therapeutics's grant share as of January 2024 was 36%. Grant share is based on the ratio of number of grants to total number of patents.
Pharmaceutical composition for treating various diseases
A pharmaceutical composition for treating various diseases and disorders has been patented, comprising specific ratios of pharmaceutically acceptable oil, propylene glycol laurates composition, polysorbate 80, and Compound 1. The composition is stable under different storage conditions and shows minimal impurity levels and degradation over time. Additionally, the patent includes methods for preparing the pharmaceutical composition and administering it to patients in need, with specific dosages and administration durations outlined.
The patent covers a wide range of applications for the pharmaceutical composition, including treating a-synucleinpathy, tauopathy, liver diseases, dementia, and reperfusion injury. The composition can be administered orally in capsule form, with specific dosages and administration protocols provided. The patent also includes methods for preparing the composition and ensuring its stability during storage. Furthermore, the composition can be administered with or without a flavorant, and its bioavailability can vary based on the type of food it is administered with. Overall, the patent provides a comprehensive overview of the pharmaceutical composition's formulation, preparation, administration, and potential therapeutic uses.
To know more about GlobalData’s detailed insights on PTC Therapeutics, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
